Effects of switching from calcium carbonate to lanthanum carbonate on bone mineral metabolism in hemodialysis patients

Therapeutic Apheresis and Dialysis

Volumn 17, Issue SUPPL. 1, 2013, Pages 35-40

  Manabe, Rie ^a   Fukami, Kei ^a   Ando, Ryotaro ^a   Sakai, Kazuko ^a   Kusumoto, Takuo ^a   Hazama, Takuma ^a   Adachi, Takeki ^a   Kaida, Yusuke ^a   Nakayama, Yosuke ^a   Ueda, Seiji ^a   Kohno, Keisuke ^c   Wada, Yoshifumi ^c   Yamagishi, Sho Ichi ^b   Okuda, Seiya ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications ^*  (Japan)

^c Wada Cardiovascular Clinic   (Japan)

Author keywords

Calcium carbonate; Hemodialysis; IL 6; Lanthanum carbonate; Vitamin D

Indexed keywords

ALFACALCIDOL; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; INTERLEUKIN 6; LANTHANUM CARBONATE; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AGED; ARTICLE; BONE MINERAL; BONE MINERAL METABOLISM; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; DRUG EFFECT; DRUG SUBSTITUTION; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MALE; MINERAL METABOLISM; MULTICENTER STUDY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION;

AGED; BONE AND BONES; CALCIUM; CALCIUM CARBONATE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INTERLEUKIN-6; LANTHANUM; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHORUS; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; RENAL DIALYSIS; RNA, MESSENGER; VITAMIN D;

EID: 84876441180     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/1744-9987.12037     Document Type: Article

References (19)

1. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001;38:938-942.
2. Fukagawa M, Yokoyama K, Koiwa F etal. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder (CKD-MBD). Ther Apher Dial 2013;17 (in press).
3. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G. Investigators, CARET: relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 2005;112:2627-2633.
4. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208-2218.
5. El-Shehaby AM, Zakaria A, El-Khatib M, Mostafa N. Association of fetuin-A and cardiac calcification and inflammation levels in hemodialysis patients. Scand J Clin Lab Invest 2010;70:575-582.
6. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008;168:1629-1637.
7. Watson KE, Abrolat ML, Malone LL etal. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997;96:1755-1760.
8. Shoji T, Shinohara K, Kimoto E etal. Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant 2004;19:179-184.
9. Teng M, Wolf M, Ofsthun MN etal. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 2005;16:1115-1125.
10. Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K. Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med 2008;168:397-403.
11. Al-Baaj F, Speake M, Hutchison AJ. Control of serum phosphate by oral lanthanum carbonate in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis in a short-term, placebo-controlled study. Nephrol Dial Transplant 2005;20:775-782.
12. Adachi T, Fukami K, Yamagishi S etal. Decreased serum carnitine is independently correlated with increased tissue accumulation levels of advanced glycation end products in haemodialysis patients. Nephrology (Carlton) 2012;17:689-694.
13. Takamiya Y, Fukami K, Yamagishi SI etal. Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice. Nephrol Dial Transplant 2013;28:55-62.
14. Inaguma D, Nagaya H, Hara K etal. Relationship between serum 1, 25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease. Clin Exp Nephrol 2008;12:126-131.
15. Fujii H. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Effect of vitamin D on kidney and cardiovascular system.] Clin Calcium 2010;20:1045-1050.
16. Li YC. Renoprotective effects of vitamin D analogs. Kidney Int 2010;78:134-139.
17. Stenvinkel P, Ketteler M, Johnson RJ etal. IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of Uremia-the good, the bad, and the ugly. Kidney Int 2005;67:1216-1233.
18. Barreto DV, Barreto FC, Liabeuf S etal. (EUTox), EUTWG: plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease. Kidney Int 2010;77:550-556.
19. Liu H, Zhang C, Huang K. Lanthanum chloride suppresses oxysterol-induced ECV-304 cell apoptosis via inhibition of intracellular Ca(2+) concentration elevation, oxidative stress, and activation of ERK and NF-κB signaling pathways. J Biol Inorg Chem 2011;16:671-681.